News
Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...
Zacks Investment Research on MSN15h
Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
Zacks Investment Research on MSN19h
Is Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback